Meta-analysis in a fixed-effect model (I2 = 0.0%, P = 0.845) showed that higher expression level of lncRNA PVT1 is associated with poorer OS for patients with GC (HR = 1.68, 95% CI: 1.43~1.97, P = 0.000) (Figure 5). Here, PVT1 is linked to gastric cancer.